Literature DB >> 11054755

Utility of an EMG mapping study in treating cervical dystonia.

J A Van Gerpen1, J Y Matsumoto, J E Ahlskog, D M Maraganore, P G McManis.   

Abstract

Intramuscular injections of botulinum toxin are the cornerstone of treatment for cervical dystonia. Controversy exists regarding the necessity for EMG-guided injections. We compared the clinical examination of four movement disorder specialists to an electromyographic (EMG) mapping study. Clinical predictions of individual muscle involvement were only 59% sensitive and 75% specific. Muscle hypertrophy, shoulder elevation, and dominant head vector did not bolster clinical accuracy. An EMG mapping study facilitates identification of dystonic muscles in cervical dystonia, which may enhance botulinum toxin therapy. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054755     DOI: 10.1002/1097-4598(200011)23:11<1752::aid-mus12>3.0.co;2-u

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

Review 1.  Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.

Authors:  Maria Fiorella Contarino; Joost Van Den Dool; Yacov Balash; Kailash Bhatia; Nir Giladi; Johannes H Koelman; Annemette Lokkegaard; Maria J Marti; Miranda Postma; Maja Relja; Matej Skorvanek; Johannes D Speelman; Evelien Zoons; Joaquim J Ferreira; Marie Vidailhet; Alberto Albanese; Marina A J Tijssen
Journal:  Front Neurol       Date:  2017-02-24       Impact factor: 4.003

Review 2.  Focal dystonia: the role of botulinum toxin.

Authors:  R Tintner; J Jankovic
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

3.  Pivotal role of obliquus capitis inferior in torticaput revealed by single-photon emission computed tomography.

Authors:  Junhui Su; Yaowen Hu; Issa Malam Djibo; Shuzhen Chen; Yougui Pan; Xiaolong Zhang; Lizhen Pan; Lingjing Jin; Fei Teng
Journal:  J Neural Transm (Vienna)       Date:  2022-02-07       Impact factor: 3.850

4.  Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.

Authors:  Olivia Samotus; Jack Lee; Mandar Jog
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

Review 5.  Update on treatments for dystonia.

Authors:  D Cristopher Bragg; Nutan Sharma
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

6.  Comparison between (18)F-FDG PET/CT and EMG Mapping for Identifying Dystonic Superficial Muscles in Primary Cervical Dystonia: Preliminary Results.

Authors:  Su Jin Jang; Joon Young Choi; Duk Hyun Sung; Kwang Hong Park; Ji Young Lee; Sook Kyung Cho; Jang Yu; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2010-02-26

Review 7.  Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance.

Authors:  Anna Castagna; Alberto Albanese
Journal:  Neurol Clin Pract       Date:  2019-02

8.  Multichannel Electromyographic Mapping to Optimize OnabotulinumtoxinA Efficacy in Cervical Dystonia.

Authors:  Camilla Kilbane; Jill Ostrem; Nicholas Galifianakis; Jamie Grace; Leslie Markun; Graham A Glass
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-08-28

Review 9.  Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A.

Authors:  Reversa R Mills; Fernando L Pagan
Journal:  Patient Prefer Adherence       Date:  2015-06-02       Impact factor: 2.711

10.  Usefulness of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in management of cervical dystonia.

Authors:  Han Byul Lee; Young-Sil An; Hyun Young Lee; Jee Hyun Hwang; Hyun Jung Lee; Kil Yong Jeong; Jong Woo Kim; Shin-Young Yim
Journal:  Ann Rehabil Med       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.